Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms UP 1010, UP1010 |
Target |
Action inhibitors |
Mechanism IRF4 inhibitors(Interferon regulatory factor 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Discovery | South Korea | 07 Jun 2024 | |
Neoplasms | Discovery | South Korea | 07 Jun 2024 |